OTCM
MEDVF
Market cap2kUSD
May 19, Last price
0.00USD
Name
Medivolve Inc
Chart & performance
P/E
—
P/S
0.01
EPS
—
Vol. 1Y
—
Shs. 5Y
63.97%
Rev. 5Y
107.97%
Div Yld LY
—
Div Yld TTM
—
Revenues
686k
-50.54%
Net income
-16m
L-10.38%
CFO
-3m
L
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
Medivolve Inc. is a primary investment firm headquartered in Toronto, Canada. Established in 2005, this company, formerly known as QuestCap Inc., channels its investments predominantly into healthcare technology, industrial enterprises, and information technology.
Key people
Chief Financial Officer · since 2013
Daniyal Baizak
Director · since 2019
Daniel Callow
Director · since 2020
Director · since 2014
G. Scott Scott Moore
Executive Chairman of the Board · since 2019
Independent Director · since 2011
Independent Director · since 2013
Legal address
1500-2828 boul. Laurier
Quebec City, QC QC G1V 0B9
CA
Quebec City, QC QC G1V 0B9
CA
Headquarters
65 Queen Street West, Suite 800
Toronto, ON M5H 2M5
CA
Toronto, ON M5H 2M5
CA
Valuation
Title CAD in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|---|
| 2023‑12 | 2022‑12 | 2021‑12 | 2020‑12 | 2019‑12 | 2018‑12 | 2017‑12 | 2016‑12 | |
| Income | ||||||||
Revenues | ||||||||
Cost of revenue | ||||||||
Unusual Expense (Income) | ||||||||
NOPBT | ||||||||
NOPBT Margin | ||||||||
Operating Taxes | ||||||||
Tax Rate | ||||||||
NOPAT | ||||||||
Net income | ||||||||
Dividends | ||||||||
Dividend yield | ||||||||
Proceeds from repurchase of equity | ||||||||
BB yield | ||||||||
| Debt | ||||||||
Debt current | ||||||||
Long-term debt | ||||||||
Deferred revenue | ||||||||
Other long-term liabilities | ||||||||
Net debt | ||||||||
| Cash flow | ||||||||
Cash from operating activities | ||||||||
CAPEX | ||||||||
Cash from investing activities | ||||||||
Cash from financing activities | ||||||||
FCF | ||||||||
| Balance | ||||||||
Cash | ||||||||
Long term investments | ||||||||
Excess cash | ||||||||
Stockholders' equity | ||||||||
Invested Capital | ||||||||
ROIC | ||||||||
ROCE | ||||||||
| EV | ||||||||
Common stock shares outstanding | ||||||||
Price | ||||||||
Market cap | ||||||||
EV | ||||||||
EBITDA | ||||||||
EV/EBITDA | ||||||||
Interest | ||||||||
Interest/NOPBT | ||||||||